Related Experiment Video
Updated: Sep 28, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Nuclear Tkt promotes ischemic heart failure via the cleaved Parp1/Aif axis
Zhiyan Wang1,2, Zeping Qiu1,2, Sha Hua3
1Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200023, People's Republic of China.
Abstract:
Transketolase (Tkt), an enzyme in pentose phosphate pathway, has been reported to regulate genome instability and cell survival in cancers. Yet, the role of Tkt after myocardial ischemic injury remains to be elucidated. Label-free proteomics revealed dramatic elevation of Tkt in murine hearts after myocardial infarction (MI). Lentivirus-mediated Tkt knockdown ameliorated cardiomyocyte apoptosis and preserved the systolic function after myocardial ischemic injury. In contrast, Tkt overexpression led to the opposite effects. Inducible conditional cardiomyocyte Tkt-knockout mice were generated, and cardiomyocyte-expressed Tkt was found to play an intrinsic role in the ischemic heart failure of these model mice. Furthermore, through luciferase assay and chromatin immunoprecipitation, Tkt was shown to be a direct target of transcription factor Krüppel-like factor 5 (Klf5). In cardiomyocytes under ischemic stress, Tkt redistributed into the nucleus. By binding with the full-length poly(ADP-ribose) polymerase 1 (Parp1), facilitating its cleavage, and activating apoptosis inducible factor (Aif) subsequently, nuclear Tkt demonstrated its non-metabolic functions. Overall, our study confirmed that elevated nuclear Tkt plays a noncanonical role in promoting cardiomyocyte apoptosis via the cleaved Parp1/Aif pathway, leading to the deterioration of cardiac dysfunction.
Insights
Transketolase (Tkt) elevation worsens heart attack outcomes by promoting heart cell death. Inhibiting Tkt in heart cells protects against cardiac dysfunction following ischemic injury.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Enzymology
Background:
- Transketolase (Tkt) is known to affect cancer cell survival and genome stability.
- Its role in cardiac ischemic injury, such as myocardial infarction (MI), is not well understood.
Purpose of the Study:
- To investigate the function of Transketolase (Tkt) in the context of myocardial ischemic injury.
- To elucidate the molecular mechanisms by which Tkt influences cardiomyocyte apoptosis and cardiac function.
Main Methods:
- Label-free proteomics to identify protein changes in murine hearts post-MI.
- Lentivirus-mediated Tkt knockdown and overexpression in cardiomyocytes.
- Generation of inducible conditional cardiomyocyte Tkt-knockout mice.
- Luciferase assay and chromatin immunoprecipitation to determine Tkt's transcriptional regulation.
- Analysis of Tkt's interaction with Poly(ADP-ribose) polymerase 1 (Parp1) and Apoptosis Inducible Factor (Aif).
Main Results:
- Proteomics revealed significantly elevated Tkt levels in hearts after MI.
- Tkt knockdown improved cardiac function and reduced cardiomyocyte apoptosis post-MI, while overexpression worsened outcomes.
- Cardiomyocyte-specific Tkt knockout mice exhibited reduced heart failure.
- Tkt was identified as a direct target of Krüppel-like factor 5 (Klf5).
- Nuclear Tkt directly binds to Parp1, facilitates its cleavage, and activates Aif, promoting apoptosis.
Conclusions:
- Elevated Transketolase (Tkt) plays a detrimental, non-metabolic role in ischemic heart failure.
- Nuclear Tkt promotes cardiomyocyte apoptosis through the Parp1/Aif pathway, contributing to cardiac dysfunction.
- Targeting Tkt may offer a therapeutic strategy for myocardial ischemic injury.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Restarting Stalled Replication Forks
Pathophysiology of Heart Failure
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

